[Trial of L-dopa as hypotensive medication in arterial hypertension. Preliminary report].
D000284:Administration, Oral; D000328:Adult; D000959:Antihypertensive Agents; D001794:Blood Pressure / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D004298:Dopamine / Q000652:urine; D004837:Epinephrine / Q000652:urine; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000652:urine; D010919:Placebos; D013997:Time Factors
D000959:Antihypertensive Agents; D010919:Placebos; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine
Ensayo de la L-dopa como medicación hipotensora en hipertensión arterial. Communicación preliminar